Hindustantimes wants to start sending you push notifications. Click allow to subscribe

serum institute of india


SII's Adar Poonawalla expects Omicron-specific vaccine in 6 months: Report

Adar Poonawalla, CEO of Serum Institute of India (SII), the world's biggest vaccine maker.
Published on Aug 15, 2022 11:36 PM IST

Monkeypox: As India sees rise in cases, what Adar Poonawalla said about vaccine

Adar Poonawalla, chief executive officer of Serum Institute of India Ltd. (Bloomberg)
Published on Aug 02, 2022 05:41 PM IST

Serum institute seeks government nod to export Covovax to the US

SII chief executive officer Adar Poonawalla. (REUTERS)
Published on Jul 01, 2022 03:16 AM IST

Govt panel recommends market authorisation for Serum's cervical cancer vaccine

The SII is also learnt to have made a presentation before the working group of HPV constituted separately by the NTAGI to review the data and usefulness of this vaccine last Wednesday.
Published on Jun 15, 2022 10:37 PM IST

Covovax gets govt nod for 12-18 age group at private centres

Currently, while Covishield is available for all adults, Bharat Biotech’s Covaxin is available for those aged 15 and above. Corbevax is being used for children in the 12-15 age group (HT FILE)
Published on May 04, 2022 12:49 AM IST
Start 15 Days Free Trial Subscribe Now